Residual Impurities in Biologics: Key Targets and Analytical Considerations for Quality Control
Biologics are produced through complex biological and manufacturing processes, and the resulting products may contain trace amounts of substances that are not part of the intended therapeutic or functional component. These residual impurities can originate from host cells, production reagents, purification processes, or other stages of manufacturing. Monitoring these substances is therefore an...
0 Комментарии 0 Поделились 85 Просмотры 0 предпросмотр